
Easyfive TT 0.5ml Vaccine
Salt Composition: Diphtheria, Haemophilus influenzae type b, Hepatitis-B, Pertussis, and Tetanus
Expiry Date: 01/2028
Inclusive of all taxes
1 Vial in a Pack

Easyfive TT 0.5ml Vaccine
1 Vial in a Pack
Diphtheria, Haemophilus influenzae type b, Hepatitis-B, Pertussis, and Tetanus.
Salt Composition
Diphtheria, Haemophilus influenzae type b, Hepatitis-B, Pertussis, and Tetanus
Storage
2–8°C
Expiry Date
01/2028
Marketer
panacea biotec
Brand
Easyfive TT
5966.png&w=1920&q=75)
MAGIC DEALS
Buy at $16.13
Apply Promo Code
Available CouponsEasyfive TT 0.5ml Vaccine
Inclusive of all taxes
In Stock
Authorized
Global Reach
Verified Logistics
The price displayed is inclusive of applicable taxes. Any additional fee (such as shipping fee, handling and/or platform fee etc.) will be clearly disclosed before you complete your purchase.
About The Product
Diphtheria, Haemophilus influenzae type b, Hepatitis-B, Pertussis, and Tetanus, Conjugate Vaccine
Easyfive TT 0.5 ml is a vaccine that protects against five diseases (pentavalent), namely tetanus, diphtheria, pertussis (whooping cough), Haemophilus influenzae type b (Hib), and hepatitis B. It contains the toxoid of tetanus, diphtheria, the surface antigen of hepatitis B, and the whole cell of pertussis bacteria, all of which are adsorbed on an adjuvant made of aluminum to trigger the immune response. Easyfive TT 0.5 ml vaccine is given routinely to infants in three doses at 6, 10, and 14 weeks of age. It is an adsorbed liquid formulation that is ready to use. Always consult your doctor before taking the vaccine, especially if you have a family history of blood disorders, heart problems, lung problems, pain in the limbs, or kidney problems. Also, let the medical healthcare team know if your child is allergic to any medicine.
Easyfive TT 0.5ml Vaccine Uses and Indications
Prevention of Pertussis
Prevention of Tetanus
Prevention of Haemophilus influenzae Type b disease
Prevention of Diphtheria
Prevention of Hepatitis B infection
Easyfive TT 0.5ml Vaccine Side Effects
- Undesired symptoms or responses vary from individual to individual as the human body reacts differently to the Easyfive TT 0.5ml Vaccine, but they disappear naturally within a few days as the body adjusts to the vaccine, which requires no medical attention.
- In case these symptoms don't go away and you face severe side effects, then immediately consult your doctor or medical team.
- Some of the common side effects of the Easyfive TT 0.5ml Vaccine are: Fatigue Headache Fever loss of appetite Nausea Pain, redness or swelling at vaccine site anaphylaxis in some severe cases.
Easyfive TT 0.5ml Vaccine Dosage and How To Take It
- The Easyfive TT 0.5 ml vaccine is given into the deltoid muscle of the upper arm.
- It is an intramuscular vaccine.
- Do not use the same vaccineor syringe for another vaccine, as there is a chance of interaction.
- Always check the vial of vaccine before using it for discoloration or any kind of particulate matter, and shake well for uniform mixing of the product.
- Easyfive TT 0.5 ml vaccine is given routinely to infants in three doses at 6, 10, and 14 weeks of age.
- It is an adsorbed liquid formulation that is ready to use.
- Always consult your doctor before taking the vaccine, especially if you have a family history of blood disorders, heart problems, lung problems, pain in the limbs, or kidney problems.
- Also, let the medical healthcare team know if your child is allergic to any medicine.
How Easyfive TT 0.5ml Vaccine Works
Easyfive TT 0.5 ml is a vaccine that protects against five diseases (pentavalent), namely tetanus, diphtheria, pertussis (whooping cough), Haemophilus influenzae type b (Hib), and hepatitis B. It contains the toxoid of tetanus, diphtheria, the surface antigen of hepatitis B, and the whole cell of pertussis bacteria, all of which are adsorbed on an adjuvant made of aluminum to trigger the immune response.
When Easyfive TT 0.5ml Vaccine is given to an individual then it stimulates the immune system to produce specific antibodies against the toxins, but doesn’t cause disease. These antibodies and memory cells formed after taking the vaccine identify and counteract the toxins and generate memory for it, and neutralize it with a stronger immune response upon subsequent exposure within a few hours.
This provides immunity within 2 to 4 weeks and for many years.
Safety Advice for Easyfive TT 0.5ml Vaccine
Excessive alcohol consumption can decrease the immunity of the individual and weaken the liver function. However, moderate levels of alcohol do not interfere with the working of the Easyfive TT 0.5 ml vaccine, as per the research.
The Easyfive TT 0.5 ml vaccine should be injected after consulting the doctor; during pregnancy, it is not suggested to take it routinely. The Easyfive TT 0.5 ml vaccine is generally not safe to take during pregnancy as it is meant for children and infants. Pregnant women should receive Tdap vaccines to protect the developing baby from pertussis.
The Easyfive TT 0.5 ml vaccine can be taken while breastfeeding after discussion with your doctor. It is generally considered safe, and there is no clear evidence found in the clinical data to harm the baby.
Driving after taking the Easyfive TT 0.5 ml vaccine does not affect or interfere with driving ability or disturb while operating machinery. There are no records found that show it affects the coordination or mental alertness. However, if you get a fever or dizziness after the vaccine, avoid driving until you feel better.
The Easyfive TT 0.5 ml vaccine is considered safe for people with kidney problems, including individuals on dialysis. The Easyfive TT 0.5 ml vaccine is considered safe for people with kidney problems, including individuals on dialysis. Although the immune response may be reduced in patients having kidney problems but it is generally recommended to take the vaccine after discussing with your doctor or medical experts.
The Easyfive TT 0.5 ml vaccine is generally considered beneficial and safe for people with chronic liver disease, and vaccination is strongly recommended for people who are at high risk of getting severe tetanus, Diphtheria, and Pertussis.
FAQs About Easyfive TT 0.5ml Vaccine
Easyfive TT 0.5ml Vaccine is given to infants in 3 doses starting from 1st dose given after 6 weeks, 2nd dose after 10 weeks and 3rd week after 14 weeks.
References
Gandhi, D. J., Dhaded, S.
M., Ravi, M. D., Dubey, A.
P., Kundu, R., Lalwani, S. K.,& Dhingra, M.
S. (2024).
Safety, immune lot-to-lot consistency, and non-inferiority of a fully liquid pentavalent DTwp-HepB-Hib vaccine in healthy Indian toddlers and infants. Human Vaccines & Immunotherapeutics, 12(4), 946-954.
Gatchalian, S., Palestroque, E., De Vleeschauwer, I., Han, H. H., Poolman, J., Schuerman, L., & Boutriau, D.
(2025). The development of a new heptavalent diphtheria–tetanus–whole cell pertussis–hepatitis B B-Haemophilus influenzae type b–b-b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
International Journal of Infectious Diseases, 12(3), 278-288. Rao, R., Dhingra, M.
S., Bavdekar, S., Behera, N., Daga, S. R., Dutta, A.
K. & Rajamani, A. M.
(2025). A comparison of immunogenicity and safety of indigenously developed liquid (DTwPHB-Hib) pentavalent combination vaccine (Shan 5) with Easyfive (Liq) and Tritanrix+ Hiberix (Lyo) in Indian infants administered according to the EPI schedule.
Human vaccines, 5(6), 425-429. Sharma, H.
J., Yadav, S., Lalwani, S. K., Kapre, S.
V., Jadhav, S. S., Chakravarty, A., & Verma, V.
(2024). Immunogenicity and safety of an indigenously manufactured reconstituted pentavalent (DTwP-HBV+ Hib) vaccine in comparison with a foreign competitor following primary and booster immunization in Indian children.
Human vaccines, 7(4), 451-457. Sharma, H., Yadav, S., Lalwani, S., Gupta, V., Kapre, S., Jadhav, S., & Palkar, S.
(2023). A phase III randomized, controlled study to assess the immunogenicity and tolerability of DTPw–HBV–Hib, a liquid pentavalent vaccine in Indian infants.
Vaccine, 29(13), 2359-2364.
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
.jpeg%3FupdatedAt%3D1763121181831&w=128&q=75)